Tumour progression and the nature of cancer
- PMID: 1911211
- PMCID: PMC1977704
- DOI: 10.1038/bjc.1991.375
Tumour progression and the nature of cancer
Abstract
The nature of neoplasia and its sometime end result, cancer, has been studied by exposition and explanation of the sequential lesions of tumour progression. Neoplastic lesions were divided into four classes on the basis of growth characteristics and whether lesional growth is confined to one or more tissue compartments. Class IA, the initial lesion, an orderly, probably clonal growth, usually differentiates and disappears. Class IB: Failure to differentiate accompanied by disorderly growth. Class IC: Randomly dispersed atypical cells, constituting a precursor state. Class II, intermediate lesions, apparently arising from the atypical cells, show temporally unrestricted growth within the tissue compartment of origin. Class III lesions, primary invasive cancers, show temporally unrestricted growth in two or more tissue compartments and metastasise along different paths, a property associated with extracellular matrix interaction. The metastatic pathways may result from different subsets of cells in the primary cancer. Class IV lesions are the metastases. It was concluded that, all neoplasms develop in the same way, have the same general behavioural characteristics, and, when malignant, all interact with the extracellular matrix of the primary and the secondary sites. The origins and development of cancer are considered to be pluralistic and not due to a discrete change in a cell, whose progeny, as a result of that discrete change, carries all of the information required to explain the almost limitless events of a neoplastic system.
Similar articles
-
Triggering the cellular change to neoplasia.Urology. 1984 Apr;23(4 Suppl):9-17. doi: 10.1016/s0090-4295(84)80062-x. Urology. 1984. PMID: 6369723 Review. No abstract available.
-
The nature of cancer: morphogenesis and progressive (self)-disorganization in neoplastic development and progression.Acta Oncol. 1995;34(1):3-21. doi: 10.3109/02841869509093632. Acta Oncol. 1995. PMID: 7865232 Review.
-
[Rearrangements in cell populations in malignant growth].Eksp Onkol. 1984;6(6):25-30. Eksp Onkol. 1984. PMID: 6396066 Review. Russian.
-
[Mitotic regime study in the morphological diagnosis of tumors].Arkh Patol. 1980;42(2):77-83. Arkh Patol. 1980. PMID: 7362480 Russian.
-
Decreased expression of human melanoma-associated antigen ME491 along the progression of melanoma pre-canceroses to invasive and metastatic melanomas.Melanoma Res. 1993 Aug;3(4):241-5. Melanoma Res. 1993. PMID: 8219756
Cited by
-
Prognostic Significance of Peripheral T-Cell Subsets in Laryngeal Squamous Cell Carcinoma.Laryngoscope Investig Otolaryngol. 2019 Aug 28;4(5):513-519. doi: 10.1002/lio2.304. eCollection 2019 Oct. Laryngoscope Investig Otolaryngol. 2019. PMID: 31637295 Free PMC article.
-
Diverse roles of epidermal growth factors receptors in oral and cutaneous canine melanomas.BMC Vet Res. 2020 Jan 29;16(1):24. doi: 10.1186/s12917-020-2249-2. BMC Vet Res. 2020. PMID: 31996230 Free PMC article.
-
Carcino-Evo-Devo, A Theory of the Evolutionary Role of Hereditary Tumors.Int J Mol Sci. 2023 May 11;24(10):8611. doi: 10.3390/ijms24108611. Int J Mol Sci. 2023. PMID: 37239953 Free PMC article. Review.
-
Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapy.Br J Cancer. 2016 Jul 12;115(2):195-202. doi: 10.1038/bjc.2016.171. Br J Cancer. 2016. PMID: 27404586 Free PMC article.
-
Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigm.Am J Pathol. 1992 Sep;141(3):519-24. Am J Pathol. 1992. PMID: 1519660 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources